Company intelligence / Profile preview

BioDynamics Research

Rushden, Northamptonshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

BioDynamics Research was a specialist Contract Research Organization (CRO) based in the United Kingdom, providing metabolism and pharmacokinetics services to the pharmaceutical and biotechnology industries. The company offered expertise in in vitro and in vivo drug metabolism, radiochemical synthesis, and bioanalytical services to support drug discovery and development programs. In 2008, BioDynamics Research was acquired by Quotient Bioresearch, a move that significantly expanded Quotient's capabilities in early-stage drug development. The company's facilities and expertise were eventually integrated into Quotient Sciences, where they continue to support global drug development efforts.

Modalities: Small molecule
Industry: Contract Research Organization

Beyond the preview

Go deeper on BioDynamics Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDynamics Research.

Explore the full profile